Simplex Trading, LLC Vyne Therapeutics Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.24 - $4.27 $13 - $239	-56 Reduced 69.14%	25 $0
Q2 2022 Aug 03, 2022	BUY	$0.37 - $0.71 $29 - $57	81 New	81 $0
Q1 2022 May 02, 2022	SELL	$0.5 - $1.15 $984 - $2,263	-1,968 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$0.91 - $1.5 $1,790 - $2,952	1,968 New	1,968 $2,000
Q2 2021 Aug 12, 2021	SELL	$3.24 - $6.92 $23,328 - $49,824	-7,200 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$6.34 - $12.68 $45,648 - $91,296	7,200 New	7,200 $49,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $170M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.